The combined immunohistochemical expression of two protein biomarkers, AMBRA1 and Loricrin in the epidermis overlying a primary melanoma as compared with expression in the normal epidermis in the same excision biopsy, has been identified as a novel prognostic biomarker for early AJCC stage I melanomas [7]. This evidence concerns the gene LORICRIN and melanoma.